LexAurum Advisors LLC Sells 577 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

LexAurum Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 9,512 shares of the healthcare conglomerate’s stock after selling 577 shares during the period. UnitedHealth Group accounts for approximately 1.0% of LexAurum Advisors LLC’s portfolio, making the stock its 25th largest holding. LexAurum Advisors LLC’s holdings in UnitedHealth Group were worth $4,982,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Waycross Partners LLC increased its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the period. Sherbrooke Park Advisers LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $515,000. Full Sail Capital LLC grew its holdings in shares of UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate’s stock worth $815,000 after purchasing an additional 33 shares in the last quarter. Soros Fund Management LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth about $39,413,000. Finally, Silvercrest Asset Management Group LLC grew its holdings in shares of UnitedHealth Group by 47.8% during the fourth quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock worth $19,625,000 after purchasing an additional 12,550 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of UnitedHealth Group stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average price of $312.16 per share, with a total value of $93,648.00. Following the transaction, the director now directly owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Kristen Gil purchased 3,700 shares of UnitedHealth Group stock in a transaction dated Thursday, May 15th. The shares were acquired at an average cost of $271.17 per share, with a total value of $1,003,329.00. Following the transaction, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders acquired 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Hsbc Global Res lowered UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a report on Wednesday, May 21st. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Truist Financial reissued a “buy” rating and set a $360.00 price objective (down previously from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wall Street Zen downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Finally, TD Securities reiterated a “hold” rating and issued a $308.00 price target (down previously from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $428.43.

UnitedHealth Group Price Performance

UNH opened at $303.24 on Friday. The stock has a 50-day moving average price of $409.03 and a 200-day moving average price of $483.40. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $275.08 billion, a PE ratio of 19.56, a P/E/G ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the prior year, the firm earned $6.91 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be given a $2.21 dividend. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. The ex-dividend date is Monday, June 16th. This represents a $8.84 dividend on an annualized basis and a yield of 2.92%. UnitedHealth Group’s payout ratio is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.